1. Home
  2. ABEO vs LND Comparison

ABEO vs LND Comparison

Compare ABEO & LND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • LND
  • Stock Information
  • Founded
  • ABEO 1974
  • LND 2005
  • Country
  • ABEO United States
  • LND Brazil
  • Employees
  • ABEO N/A
  • LND N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • LND Farming/Seeds/Milling
  • Sector
  • ABEO Health Care
  • LND Consumer Staples
  • Exchange
  • ABEO Nasdaq
  • LND Nasdaq
  • Market Cap
  • ABEO 332.0M
  • LND 375.6M
  • IPO Year
  • ABEO 1980
  • LND 2006
  • Fundamental
  • Price
  • ABEO $6.26
  • LND $3.75
  • Analyst Decision
  • ABEO Strong Buy
  • LND
  • Analyst Count
  • ABEO 6
  • LND 0
  • Target Price
  • ABEO $18.00
  • LND N/A
  • AVG Volume (30 Days)
  • ABEO 611.9K
  • LND 26.4K
  • Earning Date
  • ABEO 08-19-2025
  • LND 09-03-2025
  • Dividend Yield
  • ABEO N/A
  • LND 6.53%
  • EPS Growth
  • ABEO N/A
  • LND 29.70
  • EPS
  • ABEO N/A
  • LND 0.54
  • Revenue
  • ABEO N/A
  • LND $214,643,237.00
  • Revenue This Year
  • ABEO N/A
  • LND $55.76
  • Revenue Next Year
  • ABEO $322.37
  • LND N/A
  • P/E Ratio
  • ABEO N/A
  • LND $6.93
  • Revenue Growth
  • ABEO N/A
  • LND 8.74
  • 52 Week Low
  • ABEO $3.93
  • LND $3.49
  • 52 Week High
  • ABEO $7.32
  • LND $4.97
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 47.50
  • LND 47.09
  • Support Level
  • ABEO $6.18
  • LND $3.69
  • Resistance Level
  • ABEO $6.94
  • LND $3.75
  • Average True Range (ATR)
  • ABEO 0.27
  • LND 0.06
  • MACD
  • ABEO -0.05
  • LND 0.01
  • Stochastic Oscillator
  • ABEO 18.07
  • LND 35.29

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About LND Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

Brasilagro - Cia Bras de Prop Agricolas is a Brazil-based company, engaged in the acquisition, development, operation, and sale of rural properties suitable for agricultural activities. The business activity of the firm is operated through Real estate, Grains, Sugarcane, Cattle rising, Cotton, and Other segments. The Grains segment is involved in the production and sale of soybean and corn. The Sugarcane segment includes the sale of raw product. The Real Estate segment presents the P&L from operations carried out in the company's subsidiaries. The Cattle Raising segment consists of producing and selling beef calves after weaning, which characterizes the activity as breeding and the Other segment engages in other corporate activities. The majority of revenue is earned from Grain Segment.

Share on Social Networks: